Intra-arterial, intravitreal chemotherapy advances in retinoblastoma treatment

KOLOA, Hawaii – Chemotherapy delivered intravitreally and intra-arterially are among advances in the field of retinoblastoma treatments, according to a speaker here. “You may not take care of retinoblastoma yourself, but it’s important to be aware of the recent advances in the field,” J. William Harbour, MD, from Bascom Palmer Eye Institute, said at Retina 2014. The standard of care for treating retinoblastoma remains systemic intravenous chemotherapy using carboplatin, vincristine and etoposide, followed by local treatment with laser, Harbour said.

Full Story →